The health-related quality of life of ankylosing spondylitis patients assessed by SF-36: a systematic review and meta-analysis

Quality of Life Research

Volumn 25, Issue 11, 2016, Pages 2711-2723

  Yang, Xiao ^a   Fan, Dazhi ^a,b   Xia, Qing ^a   Wang, Mengmeng ^a   Zhang, Xu ^a   Li, Xiaona ^a   Cai, Guoqi ^a   Wang, Li ^a   Xin, Lihong ^a   Xu, Shengqian ^a   Pan, Faming ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Ankylosing spondylitis; Health related quality of life; Medical Outcomes Short Form 36 questionnaire; Meta analysis; SF 36

Indexed keywords

ANKYLOSING SPONDYLITIS; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; CLINICAL EVALUATION; DATA ANALYSIS SOFTWARE; HUMAN; MEDLINE; MENTAL HEALTH; META ANALYSIS; OUTCOME ASSESSMENT; POPULATION; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; REVIEW; SHORT FORM 36; SYSTEMATIC REVIEW; WEB OF SCIENCE; ADULT; FEMALE; MALE; PSYCHOLOGY; QUESTIONNAIRE;

ADULT; FEMALE; HUMANS; MALE; QUALITY OF LIFE; SPONDYLITIS, ANKYLOSING; SURVEYS AND QUESTIONNAIRES;

EID: 84975246040     PISSN: 09629343     EISSN: 15732649     Source Type: Journal    
DOI: 10.1007/s11136-016-1345-z     Document Type: Review

References (84)

1. Braun, J., & Sieper, J. (2007). Ankylosing spondylitis. Lancet, 369(9570), 1379–1390. doi:10.1016/S0140-6736(07)60635-7.
2. Gran, J. T., & Husby, G. (1993). The epidemiology of ankylosing spondylitis. Seminars in Arthritis and Rheumatism, 22(5), 319–334.
3. Exarchou, S., Lie, E., Lindstrom, U., Askling, J., Forsblad-d’Elia, H., Turesson, C., et al. (2015). Mortality in ankylosing spondylitis: results from a nationwide population-based study. Annals of the Rheumatic Diseases,. doi:10.1136/annrheumdis-2015-207688.
4. Feldtkeller, E., Khan, M. A., van der Heijde, D., van der Linden, S., & Braun, J. (2003). Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatology International, 23(2), 61–66.
5. Ward, M. M., Weisman, M. H., Davis, J. C, Jr., & Reveille, J. D. (2005). Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis and Rheumatism, 53(5), 710–717. doi:10.1002/art.21444.
6. Missaoui, B., & Revel, M. (2006). Fatigue in ankylosing spondylitis. Annales de réadaptation et de médecine physique, 49(6), 305–308, 389–391. doi:10.1016/j.annrmp.2006.03.007.
7. Haywood, K. L., Packham, J. C., & Jordan, K. P. (2014). Assessing fatigue in ankylosing spondylitis: the importance of frequency and severity. Rheumatology (Oxford), 53(3), 552–556. doi:10.1093/rheumatology/ket397.
8. Bedaiwi, M., Sari, I., Thavaneswaran, A., Ayearst, R., Haroon, N., & Inman, R. D. (2015). Fatigue in ankylosing spondylitis and nonradiographic axial spondyloarthritis: Analysis from a longitudinal observation cohort. Journal of Rheumatology, 42(12), 2354–2360. doi:10.3899/jrheum.150463.
9. van Tubergen, A., Coenen, J., Landewe, R., Spoorenberg, A., Chorus, A., Boonen, A., et al. (2002). Assessment of fatigue in patients with ankylosing spondylitis: A psychometric analysis. Arthritis and Rheumatism, 47(1), 8–16.
10. Hakkou, J., Rostom, S., Mengat, M., Aissaoui, N., Bahiri, R., & Hajjaj-Hassouni, N. (2013). Sleep disturbance in Moroccan patients with ankylosing spondylitis: Prevalence and relationships with disease-specific variables, psychological status and quality of life. Rheumatology International, 33(2), 285–290. doi:10.1007/s00296-012-2376-6.
11. Boonen, A., Chorus, A., Miedema, H., van der Heijde, D., Landewe, R., Schouten, H., et al. (2001). Withdrawal from labour force due to work disability in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases, 60(11), 1033–1039.
12. Barlow, J. H., Wright, C. C., Williams, B., & Keat, A. (2001). Work disability among people with ankylosing spondylitis. Arthritis and Rheumatism, 45(5), 424–429.
13. Dincer, U., Cakar, E., Kiralp, M. Z., & Dursun, H. (2007). Assessment of sexual dysfunction in male patients with ankylosing spondylitis. Rheumatology International, 27(6), 561–566. doi:10.1007/s00296-006-0248-7.
14. Oh, J. S., Heo, H. M., Kim, Y. G., Lee, S. G., Lee, C. K., & Yoo, B. (2009). The effect of anti-tumor necrosis factor agents on sexual dysfunction in male patients with ankylosing spondylitis: A pilot study. International Journal of Impotence Research, 21(6), 372–375. doi:10.1038/ijir.2009.44.
15. Cella, D., & Nowinski, C. J. (2002). Measuring quality of life in chronic illness: The functional assessment of chronic illness therapy measurement system. Archives of Physical Medicine and Rehabilitation, 83(12 Suppl 2), S10–S17. doi:10.1053/apmr.2002.36959.
16. Ware, J., & Sherbourne, S. D. (1992). The MOS 36-item short form health survey (SF-36). 1. Conceptual frame-work and item selection. Medical Care, 30, 473–481.
17. Ware, J. E, Jr. (2000). Using generic measures of functional health and well-being to increase understanding of disease burden. Spine, 25(12), 1467.
18. Ozgul, A., Peker, F., Taskaynatan, M. A., Tan, A. K., Dincer, K., & Kalyon, T. A. (2006). Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clinical Rheumatology, 25(2), 168–174. doi:10.1007/s10067-005-1150-5.
19. Husted, J. A., Gladman, D. D., Farewell, V. T., Long, J. A., & Cook, R. J. (1997). Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. Journal of Rheumatology, 24(3), 511–517.
20. Dougados, M., & Baeten, D. (2011). Spondyloarthritis. Lancet, 377(9783), 2127–2137. doi:10.1016/S0140-6736(11)60071-8.
21. von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gotzsche, P. C., Vandenbroucke, J. P., et al. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Preventive Medicine, 45(4), 247–251.
22. Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gotzsche, P. C., Mulrow, C. D., Pocock, S. J., et al. (2014). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. International Journal of Surgery, 12(12), 1500–1524. doi:10.1016/j.ijsu.2014.07.014.
23. Matcham, F., Scott, I. C., Rayner, L., Hotopf, M., Kingsley, G. H., Norton, S., et al. (2014). The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 44(2), 123–130. doi:10.1016/j.semarthrit.2014.05.001.
24. Zhang, S.-K., Guo, L.-W., Chen, Q., Zhang, M., Liu, S.-Z., Quan, P.-L., et al. (2015). Prevalence of human papillomavirus 16 in esophageal cancer among the Chinese population: A systematic review and meta-analysis. Asian Pacific Journal of Cancer Prevention, 15(23), 10143–10149. doi:10.7314/apjcp.2014.15.23.10143.
25. Yang, B., Fan, S., Zhi, X., Wang, Y., Wang, Y., Zheng, Q., et al. (2015). Prevalence of hyperhomocysteinemia in China: A systematic review and meta-analysis. Nutrients, 7(1), 74–90. doi:10.3390/nu7010074.
26. Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557–560. doi:10.1136/bmj.327.7414.557.
27. Harris, R., Bradburn, M., Deeks, J., Harbord, R., Altman, D., & Steichen, T. (2010). Stata module for fixed and random effects meta-analysis. Statistical software components. Department of Economics, Boston College, USA.
28. Ribu, L., Hanestad, B. R., Moum, T., Birkeland, K., & Rustoen, T. (2007). A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Quality of Life Research, 16(2), 179–189. doi:10.1007/s11136-006-0031-y.
29. Jenkinson, C., Coulter, A., & Wright, L. (1993). Short-form 36 (SF-36) health survey questionnaire: Normative data for adults of working age. British Medical Journal, 29, 1437–1440.
30. Clarke, P. M., Simon, J., Cull, C. A., & Holman, R. R. (2006). Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36. Diabetes Care, 29(7), 1506–1511. doi:10.2337/dc05-2150.
31. Ward, M. M. (1999). Health-related quality of life in ankylosing spondylitis: A survey of 175 patients. Arthritis Care & Research, 12(4), 247–255.
32. Tubergen, A. V., Coenen, J., Landewe, R., Spoorenberg, A., Chorus, A., Boonen, A., et al. (2002). Assessment of fatigue in patients with ankylosing spondylitis: A psychometric analysis. Arthritis and Rheumatism, 47(1), 8–16.
33. Ariza-Ariza, R., Hernandez-Cruz, B., & Navarro-Sarabia, F. (2003). Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis and Rheumatism, 49(4), 483–487. doi:10.1002/art.11197.
34. Chorus, A. M., Miedema, H. S., Boonen, A., & Van Der Linden, S. (2003). Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Annals of the Rheumatic Diseases, 62(12), 1178–1184.
35. van Tubergen, A., Landewe, R., Heuft-Dorenbosch, L., Spoorenberg, A., van der Heijde, D., van der Tempel, H., et al. (2003). Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases, 62(2), 140–145.
36. Dagfinrud, H., Mengshoel, A. M., Hagen, K. B., Loge, J. H., & Kvien, T. K. (2004). Health status of patients with ankylosing spondylitis: A comparison with the general population. Annals of the Rheumatic Diseases, 63(12), 1605–1610. doi:10.1136/ard.2003.019224.
37. Barkham, N., Kong, K. O., Tennant, A., Fraser, A., Hensor, E., Keenan, A. M., et al. (2005). The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis. Rheumatology (Oxford), 44(10), 1277–1281. doi:10.1093/rheumatology/keh713.
38. Braun, J., Brandt, J., Listing, J., Zink, A., Alten, R., Burmester, G., et al. (2005). Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Annals of the Rheumatic Diseases, 64(2), 229–234. doi:10.1136/ard.2004.025130.
39. Heiberg, M. S., Nordvag, B. Y., Mikkelsen, K., Rodevand, E., Kaufmann, C., Mowinckel, P., et al. (2005). The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: A six-month, longitudinal, observational, multicenter study. Arthritis and Rheumatism, 52(8), 2506–2512. doi:10.1002/art.21209.
40. Ozgul, A., Peker, F., Taskaynatan, M. A., Tan, A. K., Dincer, K., & Kalyon, T. A. (2006). Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clinical Rheumatology, 25(2), 168–174. doi:10.1007/s10067-005-1150-5.
41. Cakar, E., Dincer, U., Kiralp, M., Taskaynatan, M., Yasar, E., Bayman, E., et al. (2007). Sexual problems in male ankylosing spondylitis patients: relationship with functionality, disease activity, quality of life, and emotional status. Clinical Rheumatology, 26(10), 1607–1613.
42. Boonen, A., Patel, V., Traina, S., Chiou, C. F., Maetzel, A., & Tsuji, W. (2008). Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept. Journal of Rheumatology, 35(4), 662–667.
43. Choi, C. B., Kim, T. J., Park, H. J., Uhm, W. S., Jun, J. B., Bae, S. C., et al. (2008). Safety and clinical responses in ankylosing spondylitis after three months of etanercept therapy. Journal of Korean Medical Science, 23(5), 852–856. doi:10.3346/jkms.2008.23.5.852.
44. Maksymowych, W., Mallon, C., Morrow, S., Shojania, K., Olszynski, W., Wong, R., et al. (2009). Development and validation of the spondyloarthritis research consortium of Canada (SPARCC) enthesitis index. Annals of the Rheumatic Diseases, 68(6), 948–953.
45. Mustur, D., Vesovic-Potic, V., Stanisavljevic, D., Ille, T., & Ille, M. (2009). Assessment of functional disability and quality of life in patients with ankylosing spondylitis. Srpski Arhiv za Celokupno Lekarstvo, 137(9–10), 524–528.
46. Salaffi, F., Carotti, M., Gasparini, S., Intorcia, M., & Grassi, W. (2009). The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: A comparison with a selected sample of healthy people. Health and Quality Life Outcomes, 7, 25. doi:10.1186/1477-7525-7-25.
47. Deodhar, A., Braun, J., Inman, R. D., Mack, M., Parasuraman, S., Buchanan, J., et al. (2010). Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: Results from a randomized, placebo-controlled trial. Arthritis Care & Research, 62(9), 1266–1271. doi:10.1002/acr.20233.
48. Torres, T. M., Ferraz, M. B., & Ciconelli, R. M. (2010). Resource utilisation and cost of ankylosing spondylitis in Brazil. Clinical and Experimental Rheumatology, 28(4), 490–497.
49. Bodur, H., Ataman, S., Rezvani, A., Bugdayci, D. S., Cevik, R., Birtane, M., et al. (2011). Quality of life and related variables in patients with ankylosing spondylitis. Quality of Life Research, 20(4), 543–549. doi:10.1007/s11136-010-9771-9.
50. Hakkou, J., Rostom, S., Aissaoui, N., Berrada, K., Abouqal, R., Bahiri, R., et al. (2011). Psychological status in Moroccan patients with ankylosing spondylitis and its relationships with disease parameters and quality of life. Journal of Clinical Rheumatology, 17(8), 424–428.
51. Ovayolu, N., Ovayolu, O., & Karadag, G. (2011). Health-related quality of life in ankylosing spondylitis, fibromyalgia syndrome, and rheumatoid arthritis: a comparison with a selected sample of healthy individuals. Clinical Rheumatology, 30(5), 655–664.
52. Ozdemir, O. (2011). Quality of life in patients with ankylosing spondylitis: Relationships with spinal mobility, disease activity and functional status. Rheumatology International, 31(5), 605–610. doi:10.1007/s00296-009-1328-2.
53. Revicki, D. A., Rentz, A. M., Luo, M. P., & Wong, R. L. (2011). Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis. Health and Quality Life Outcomes, 9, 36. doi:10.1186/1477-7525-9-36.
54. Ibn Yacoub, Y., Amine, B., Laatiris, A., & Hajjaj-Hassouni, N. (2012). Gender and disease features in Moroccan patients with ankylosing spondylitis. Clinical Rheumatology, 31(2), 293–297. doi:10.1007/s10067-011-1819-x.
55. Packham, J. C., Jordan, K. P., Haywood, K. L., Garratt, A. M., & Healey, E. L. (2012). Evaluation of Ankylosing Spondylitis Quality of Life questionnaire: Responsiveness of a new patient-reported outcome measure. Rheumatology, 51(4), 707–714. doi:10.1093/rheumatology/ker377.
56. Pimentel-Santos, F., Pinto, T., Santos, H., Barcelos, A., Cunha, I., Branco, J., et al. (2012). Portuguese version of the bath indexes for ankylosing spondylitis patients: A cross-cultural adaptation and validation. Clinical Rheumatology, 31(2), 341–346.
57. Akad, K., Solmaz, D., Sari, I., Onen, F., Akkoc, N., & Akar, S. (2013). Performance of response scales of activity and functional measures of ankylosing spondylitis: Numerical rating scale versus visual analog scale. Rheumatology International, 33(10), 2617–2623. doi:10.1007/s00296-013-2789-x.
58. Alkan, B., Fidan, F., Erten, Ş., Aksekili, H., Alemdar, A., Eroğlu, E., et al. (2013). Fatigue and correlation with disease-specific variables, spinal mobility measures, and health-related quality of life in ankylosing spondylitis. Modern Rheumatology, 23(6), 1101–1107.
59. Cho, H., Kim, T., Kim, T. H., Lee, S., & Lee, K. H. (2013). Spinal mobility, vertebral squaring, pulmonary function, pain, fatigue, and quality of life in patients with ankylosing spondylitis. Annals of Rehabilitation Medicine, 37(5), 675–682. doi:10.5535/arm.2013.37.5.675.
60. Yigit, S., Sahin, Z., Demir, S., & Aytac, D. (2013). Home-based exercise therapy in ankylosing spondylitis: short-term prospective study in patients receiving tumor necrosis factor alpha inhibitors. Rheumatology International, 33(1), 71–77.
61. Yılmaz, O., Tutoğlu, A., Garip, Y., Ozcan, E., & Bodur, H. (2013). Health-related quality of life in Turkish patients with ankylosing spondylitis: impact of peripheral involvement on quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning. Rheumatology International, 33(5), 1159–1163.
62. Bao, C., Huang, F., Khan, M. A., Fei, K., Wu, Z., Han, C., et al. (2014). Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial. Rheumatology (Oxford), 53(9), 1654–1663. doi:10.1093/rheumatology/keu132.
63. Dundar, U., Solak, O., Toktas, H., Demirdal, U. S., Subasi, V., Kavuncu, V., et al. (2014). Effect of aquatic exercise on ankylosing spondylitis: A randomized controlled trial. Rheumatology International, 34(11), 1505–1511. doi:10.1007/s00296-014-2980-8.
64. Osterhaus, J. T., & Purcaru, O. (2014). Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis. Arthritis Research & Therapy, 16(4), R164. doi:10.1186/Ar4680.
65. Webers, C., Essers, I., Ramiro, S., Stolwijk, C., Landewe, R., van der Heijde, D., et al. (2014). Gender-attributable differences in outcome of ankylosing spondylitis: Long-Term Results from the Outcome in Ankylosing Spondylitis International Study. Arthritis & Rheumatology, 66, S1137.
66. Erkol, İ. E., Demirci, K., Doğru, A., & Şahin, M. (2015). Ankylosing spondylitis patients with Type D personality have worse clinical status. Modern Rheumatology, 29, 1–8.
67. Jennings, F., Oliveira, H. A., de Souza, M. C., Cruz Vda, G., & Natour, J. (2015). Effects of aerobic training in patients with ankylosing spondylitis. Journal of Rheumatology, 42(12), 2347–2353. doi:10.3899/jrheum.150518.
68. Pelaez-Ballestas, I., Boonen, A., Vazquez-Mellado, J., Reyes-Lagunes, I., Hernandez-Garduno, A., Goycochea, M. V., et al. (2015). Coping strategies for health and daily-life stressors in patients with rheumatoid arthritis, ankylosing spondylitis, and gout: STROBE-compliant article. Medicine (Baltimore), 94(10), e600. doi:10.1097/MD.0000000000000600.
69. Smith, B. H., Elliott, A. M., Chambers, W. A., Smith, W. C., Hannaford, P. C., & Penny, K. (2001). The impact of chronic pain in the community. Family Practice, 18(3), 292–299.
70. Carmona, L., Ballina, J., Gabriel, R., Laffon, A., & EPISER Study Group. (2001). The burden of musculoskeletal diseases in the general population of Spain: Results from a national survey. Annals of the Rheumatic Diseases, 60(11), 1040–1045.
71. Ware, J. E, Jr. (2000). SF-36 health survey update. Spine, 25(24), 3130–3139.
72. Barlow, J. H., Macey, S. J., & Struthers, G. R. (1993). Gender, depression, and ankylosing spondylitis. Arthritis Care & Research, 6(1), 45–51.
73. Matcham, F., Rayner, L., Steer, S., & Hotopf, M. (2013). The prevalence of depression in rheumatoid arthritis: A systematic review and meta-analysis. Rheumatology (Oxford), 52(12), 2136–2148. doi:10.1093/rheumatology/ket169.
74. Petitti, D. B. (2001). Approaches to heterogeneity in meta-analysis. Statistics in Medicine, 20(23), 3625–3633.
75. Robert, S., Cherepanov, D., Palta, M., Dunham, N., Feeny, D., & Fryback, D. (2009). Socioeconomic status and age variations in health-related quality of life: results from the National Health Measurement Study. Journal of Gerontology, 64B, 378–389.
76. De Vogli, R., Gimeno, D., & Kivimaki, M. (2008). Socioeconomic inequalities in health in 22 European countries. New England Journal of Medicine, 359(12), 1290. doi:10.1056/NEJMc081414. author reply 1290–1291.
77. Kidd, B., Mullee, M., Frank, A., & Cawley, M. (1988). Disease expression of ankylosing spondylitis in males and females. The Journal of Rheumatology, 15(9), 1407–1409.
78. Gran, J. T., & Husby, G. (1990). Ankylosing spondylitis in women. Seminars in Arthritis and Rheumatism, 19(5), 303–312.
79. Jimenez-Balderas, F. J., & Mintz, G. (1993). Ankylosing spondylitis: Clinical course in women and men. The Journal of Rheumatology, 20(12), 2069–2072.
80. Blazer, D., Burchett, B., Service, C., & George, L. K. (1991). The association of age and depression among the elderly: An epidemiologic exploration. Journal of Gerontology, 46(6), M210–M215.
81. Stordal, E., Mykletun, A., & Dahl, A. A. (2003). The association between age and depression in the general population: A multivariate examination. Acta Psychiatrica Scandinavica, 107(2), 132–141.
82. Kim, S. M., Jung, J. W., Park, I. W., Ahn, C. M., Kim, Y. I., Yoo, K. H., et al. (2016). Gender differences in relations of smoking status, depression, and suicidality in Korea: Findings from the Korea National Health and Nutrition Examination Survey 2008–2012. Psychiatry Investigation, 13(2), 239–246. doi:10.4306/pi.2016.13.2.239.
83. Calin, A., Garrett, S., Whitelock, H., Kennedy, L. G., O’Hea, J., Mallorie, P., et al. (1994). A new approach to defining functional ability in AS: The development of the Bath ankylosing spondylitis functional index. Journal of Rheumatology, 21, 2281–2285.
84. Garrett, S., Jenkinson, T., Kennedy, L., Whitelock, H., Gaisford, P., & Calin, A. (1994). A new approach to defining disease status in AS: The Bath ankylosing spondylitis disease activity index. Journal of Rheumatology, 21, 2286–2291.